Insiders · Profile

Anglum Gregory O.

SVP & CFO at Bioventus. Filing since 11 Feb 2021. CIK 0001680271

Company
Date
Role
Action
Shares
Amount
Of holding
14 Feb 2022
SVP & CFO
Sold, plan not stated
1,294
$15.52K
2.3%
11 Feb 2021
SVP & General Counsel
Bought
6,000
$78.00K
opened
2 decisions on file.